[Short-term and long-term glycemic variability and its relationship to microvascular complications of diabetes]
Insights
Glycemic variability, or short-term glucose fluctuations, may link to diabetes microvascular complications like retinopathy, nephropathy, and neuropathy. This contrasts with HbA1c, which only shows long-term average blood sugar control.
Area of Science:
- Endocrinology
- Diabetology
- Vascular Medicine
Background:
- Diabetes vascular complications stem from poor glycemic control, traditionally measured by HbA1c.
- HbA1c offers limited insight into short-term glucose fluctuations, known as glycemic variability.
- Glycemic variability is increasingly studied for its potential role in diabetes pathophysiology.
Purpose of the Study:
- To review current research on glycemic variability.
- To explore the association between glycemic variability and microvascular complications in diabetes.
- To synthesize findings on retinopathy, nephropathy, and neuropathy in relation to glycemic variability.
Main Methods:
- Literature review of recent studies on glycemic variability.
- Analysis of research linking glycemic variability to diabetes complications.
- Focus on studies investigating microvascular outcomes (retinopathy, nephropathy, neuropathy).
Main Results:
- Glycemic variability may contribute to oxidative stress, endothelial dysfunction, and inflammation.
- Existing research links glycemic variability to macrovascular complications.
- The relationship between glycemic variability and microvascular complications requires further investigation.
Conclusions:
- Glycemic variability is a potential factor in diabetes-related vascular damage.
- Understanding glycemic variability may offer new insights into preventing microvascular complications.
- Further research is needed to clarify the specific associations with retinopathy, nephropathy, and neuropathy.
Abstract:
Vascular complications of diabetes result from long lasting unsatisfactory glycemic control. We usually assess glycemic control based on the value of glycated hemoglobin HbA1c. The glycated hemoglobin test, however, says nothing about short-term glycemic fluctuations. Recently, continuous monitoring of glycemia has enabled us an in-depth assessment of changes in glucose concentrations, called glycemic variability. In connection with the research into short-term glycemic variability, also the study of long-term fluctuations in glycemic control based on HbA1c variability has now intensified. Glycemic variability may be related to oxidation stress, endothelial dysfunction and inflammation, the factors traditionally associated with vascular damage. Several studies have described the relation of glycemic variability to macrovascular complications of diabetes, still its relation to microvascular complications remains unclear. This overview summarizes the recent findings in the field of glycemic variability and its possible association with retinopathy, nephropathy and neuropathy.Key words: type 1 and 2 diabetes mellitus - glycemic variability - microvascular complications - HbA1c - variability.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Hypoglycemia and Glucagon